Martini Lene, Whistler Jennifer L
Ernest Gallo Clinic and Research Center, Department of Neurology, University of California, San Francisco, 5858 Horton St. Suite 200, Emeryville, CA 94608, United States.
Curr Opin Neurobiol. 2007 Oct;17(5):556-64. doi: 10.1016/j.conb.2007.10.004. Epub 2007 Dec 18.
Following activation, most G protein coupled receptors undergo regulation by a cascade of events that promote receptor desensitization and endocytosis. Following endocytosis, receptors can then be recycled to the plasma membrane, retained in an intracellular compartment, or targeted for degradation. For receptors that are recycled, like the mu opioid receptor (MOR), endocytosis serves as the first step toward resensitizing receptors. For receptors that are degraded, endocytosis serves as the first step toward receptor downregulation. Thus, for receptors like the MOR, the desensitization-endocytosis-resensitization cycle serves as a rapid and dynamic means to titrate signaling through the receptor. However, not all agonist ligands at the MOR promote the same degree of receptor desensitization and endocytosis. For example, the endogenous peptide ligands at the MOR induce rapid desensitization, endocytosis, and recycling. By contrast, morphine induces only weak or partial desensitization and little to no endocytosis. As a consequence, signal transduction promoted by morphine is less dynamic than that induced by endogenous ligands as well as other opioid agonists that promote endocytosis. The resulting imbalance of desensitization-endocytosis-resensitization has at least two consequences: (1) in cell types where morphine induces desensitization but not endocytosis and/or resensitization, desensitization is protracted; (2) in cell types where morphine induces neither desensitization nor endocytosis, prolonged signaling through the receptor leads to multiple cellular adaptations downstream of receptor-G protein coupling. Both protracted desensitization and adaptive cellular changes probably contribute to the pronounced in vivo tolerance and dependence that occur with chronic morphine treatment. As a consequence, facilitating receptor endocytosis, using either genetic or pharmacological approaches, can restore the balance of signaling through the receptor and affect the development of tolerance and dependence.
激活后,大多数G蛋白偶联受体通过一系列促进受体脱敏和内吞作用的事件进行调节。内吞作用后,受体随后可以循环回到质膜,保留在细胞内区室中,或靶向降解。对于可循环利用的受体,如μ阿片受体(MOR),内吞作用是使受体重新敏感化的第一步。对于被降解的受体,内吞作用是受体下调的第一步。因此,对于像MOR这样的受体,脱敏-内吞-再敏感化循环是一种快速且动态的方式来调节通过该受体的信号传导。然而,并非MOR上的所有激动剂配体都能促进相同程度的受体脱敏和内吞作用。例如,MOR上的内源性肽配体可诱导快速脱敏、内吞和循环。相比之下,吗啡仅诱导微弱或部分脱敏,几乎不发生内吞作用。因此,吗啡促进的信号转导比内源性配体以及其他促进内吞作用的阿片类激动剂诱导的信号转导缺乏动态性。脱敏-内吞-再敏感化的这种失衡至少有两个后果:(1)在吗啡诱导脱敏但不诱导内吞和/或再敏感化的细胞类型中,脱敏作用持续时间延长;(2)在吗啡既不诱导脱敏也不诱导内吞的细胞类型中,通过受体的长时间信号传导会导致受体-G蛋白偶联下游的多种细胞适应性变化。持续的脱敏和适应性细胞变化可能都导致了慢性吗啡治疗中出现的明显的体内耐受性和依赖性。因此,使用基因或药理学方法促进受体内吞作用,可以恢复通过该受体的信号传导平衡,并影响耐受性和依赖性的发展。